- Nachrichtendetail
-
21.02.2024 13:12:52 - dpa-AFX: *REGENERON PHARMA: FDA ACCEPTS FOR PRIORITY REVIEW BLA FOR LINVOSELTAMAB FOR TREATMENT OF R/R MULTIPLE MYELOMA
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 901,200 | 21.05.24 08:16:38 | +2,000 | +0,22% | 898,400 | 909,200 | 902,600 | 899,200 |
